Fairmount Funds Management’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.8M Hold
3,371,922
4.9% 11
2025
Q1
$34.6M Hold
3,371,922
5.37% 10
2024
Q4
$65.4M Buy
3,371,922
+160,000
+5% +$3.1M 6.5% 8
2024
Q3
$78.7M Buy
+3,211,922
New +$78.7M 6.38% 7